Sedentary time in adults with cystic fibrosis: A prospective observational cross-sectional study - Bishop, Ines; Cobb, Robyn; Hall, Kathleen; Kuys, Suzanne (medRxiv, 2023)
Objective Adults with cystic fibrosis remain susceptible to comorbidities associated with high sedentary time, increasing their risk of poor health outcomes. Evidence about sedentary time in adults with cystic fibrosis is limited. This study investigated sedentary time and physical activity in adults with cystic fibrosis across disease severity groups and the relationship with clinical measures.Methods A SenseWear armband was worn by adults with cystic fibrosis, measuring sedentary time, time spent in moderate-vigorous physical activity and steps per day. Lung function, quadriceps strength, exercise capacity and health-related quality of life were assessed.Results On average, the armband was worn for 20 hours (Standard Deviation (SD) 6) over 6 (SD 1) days. Forty-eight participants (28 males) spent 815 (SD 379) minutes sedentary, 137 (SD 13) minutes engaged in moderate-vigorous physical activity and took 5660 (SD 2749) steps per day. Sedentary time did not vary across disease severity groups nor correlate with clinical measures.Conclusions Adults with cystic fibrosis spent a large proportion of time in sedentary behaviours, took insufficient steps, but conversely engaged in sufficient moderate-vigorous physical activity. Targeted interventions to break up sedentary time are required to reduce the risk of adverse health outcomes in this population.Impact Adults with cystic fibrosis spend a large proportion of their time sedentary, placing them at risk of future metabolic disorders. Interventions to break up sedentary time are needed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Prince Charles Hospital Human Research Ethics Committee (18908 HREC) approved this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript.